Pregnancy and Childbirth in Women with Thalassemia Yesterday and Today
Launched by FONDAZIONE PER LA RICERCA SULLE ANEMIE ED EMOGLOBINOPATIE IN ITALIA · Mar 17, 2025
Trial Information
Current as of April 22, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Transfusion dependent and nontransfusion- dependent thalassemia
- • Pregnancy ended with the birth of a live or dead foetus
- • Pregnancy ended in miscarriage or voluntary abortion
- • Pregnancy in progress
- Exclusion Criteria:
- • Other types of anemia
- • Pregnancy not initiated despite assisted fertilization practices
- • Subjects unwilling to sign informed consent
About Fondazione Per La Ricerca Sulle Anemie Ed Emoglobinopatie In Italia
Fondazione per la Ricerca sulle Anemie ed Emoglobinopatie in Italia is a dedicated research foundation focused on advancing the understanding and treatment of anemias and hemoglobinopathies. Committed to fostering innovation in clinical research, the foundation collaborates with healthcare professionals, academic institutions, and industry partners to facilitate groundbreaking studies aimed at improving patient outcomes. Through its initiatives, the foundation seeks to enhance awareness, support clinical trials, and promote the development of novel therapeutic approaches, ultimately striving to make significant contributions to the field of hematology in Italy and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cagliari, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Related Blog Entries
View all
